The identified upregulated promoters of cancer progression included NR2F1-AS1 and LINC00511 in clPTC and CRNDE in ATC; downregulated tumour suppressors SLC26A4-AS1 in clPTC and RMST in ATC. This evidence concerns the gene SLC26A4 and neoplasm.